9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Human cardiac progenitor cell activation and regeneration mechanisms: exploring a novel myocardial ischemia/reperfusion in vitro model

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Numerous studies from different labs around the world report human cardiac progenitor cells (hCPCs) as having a role in myocardial repair upon ischemia/reperfusion (I/R) injury, mainly through auto/paracrine signaling. Even though these cell populations are already being investigated in cell transplantation-based clinical trials, the mechanisms underlying their response are still poorly understood.

          Methods

          To further investigate hCPC regenerative process, we established the first in vitro human heterotypic model of myocardial I/R injury using hCPCs and human-induced pluripotent cell-derived cardiomyocytes (hiPSC-CMs). The co-culture model was established using transwell inserts and evaluated in both ischemia and reperfusion phases regarding secretion of key cytokines, hiPSC-CM viability, and hCPC proliferation. hCPC proteome in response to I/R was further characterized using advanced liquid chromatography mass spectrometry tools.

          Results

          This model recapitulates hallmarks of I/R, namely hiPSC-CM death upon insult, protective effect of hCPCs on hiPSC-CM viability (37.6% higher vs hiPSC-CM mono-culture), and hCPC proliferation (approximately threefold increase vs hCPCs mono-culture), emphasizing the importance of paracrine communication between these two populations. In particular, in co-culture supernatant upon injury, we report higher angiogenic functionality as well as a significant increase in the CXCL6 secretion rate, suggesting an important role of this chemokine in myocardial regeneration. hCPC whole proteome analysis allowed us to propose new pathways in the hCPC-mediated regenerative process, including cell cycle regulation, proliferation through EGF signaling, and reactive oxygen species detoxification.

          Conclusion

          This work contributes with new insights into hCPC biology in response to I/R, and the model established constitutes an important tool to study the molecular mechanisms involved in the myocardial regenerative process.

          Electronic supplementary material

          The online version of this article (10.1186/s13287-019-1174-4) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references49

          • Record: found
          • Abstract: found
          • Article: not found

          Molecular regulation of stem cell quiescence.

          Subsets of mammalian adult stem cells reside in the quiescent state for prolonged periods of time. This state, which is reversible, has long been viewed as dormant and with minimal basal activity. Recent advances in adult stem cell isolation have provided insights into the epigenetic, transcriptional and post-transcriptional control of quiescence and suggest that quiescence is an actively maintained state in which signalling pathways are involved in maintaining a poised state that allows rapid activation. Deciphering the molecular mechanisms regulating adult stem cell quiescence will increase our understanding of tissue regeneration mechanisms and how they are dysregulated in pathological conditions and in ageing.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            c-kit+ Cells Minimally Contribute Cardiomyocytes to the Heart

            If and how the heart regenerates after an injury event is highly debated. c-kit-expressing cardiac progenitor cells have been reported as the primary source for generation of new myocardium after injury. Here we generated two genetic approaches in mice to examine if endogenous c-kit+ cells contribute differentiated cardiomyocytes to the heart during development, with aging or after injury in adulthood. A cDNA encoding either Cre recombinase or a tamoxifen inducible MerCreMer chimeric protein was targeted to the Kit locus in mice and then bred with reporter lines to permanently mark cell lineage. Endogenous c-kit+ cells did produce new cardiomyocytes within the heart, although at a percentage of ≈0.03% or less, and if a preponderance towards cellular fusion is considered, the percentage falls below ≈0.008%. In contrast, c-kit+ cells amply generated cardiac endothelial cells. Thus, endogenous c-kit+ cells can generate cardiomyocytes within the heart, although likely at a functionally insignificant level.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Oxygen, oxidative stress, hypoxia, and heart failure

                Bookmark

                Author and article information

                Contributors
                msebastiao@ibet.pt
                mserra@ibet.pt
                ruterpereira@gmail.com
                itziar.palacio@takeda.com
                palves@ibet.pt
                +351 21 446 94 21 , marques@ibet.pt , http://tca.itqb.unl.pt
                Journal
                Stem Cell Res Ther
                Stem Cell Res Ther
                Stem Cell Research & Therapy
                BioMed Central (London )
                1757-6512
                7 March 2019
                7 March 2019
                2019
                : 10
                : 77
                Affiliations
                [1 ]GRID grid.7665.2, Animal Cell Technology Unit, , iBET, Instituto de Biologia Experimental e Tecnológica, ; Oeiras, Portugal
                [2 ]ISNI 0000000121511713, GRID grid.10772.33, ITQB-NOVA, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, ; Oeiras, Portugal
                [3 ]GRID grid.433409.9, Coretherapix, S.L.U (Tigenix Group, Takeda), Parque Tecnológico de Madrid, ; Madrid, Spain
                Article
                1174
                10.1186/s13287-019-1174-4
                6407246
                30845956
                5bdfbb74-dd63-4bbf-9900-79158ecda6c0
                © The Author(s). 2019

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 30 January 2019
                : 12 February 2019
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100001871, Fundação para a Ciência e a Tecnologia;
                Award ID: UID/Multi/04462/2013
                Award ID: MITP-TB/ECE/0013/2013
                Award ID: SAICTPAC/0047/2015
                Award ID: SFRH/BD/52339/2013
                Funded by: FundRef http://dx.doi.org/10.13039/100011199, FP7 Ideas: European Research Council;
                Award ID: HEALTH-2009_242038
                Categories
                Research
                Custom metadata
                © The Author(s) 2019

                Molecular medicine
                cardiac progenitor cells, myocardial infarction,myocardial ischemia reperfusion injury,proteomics,ischemia-reperfusion injury

                Comments

                Comment on this article